HSA Product

MOXICLAV 625 TABLET

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

MOXICLAV 625 TABLET

Dosage Form

TABLET, FILM COATED

Regulatory Information

Approval Number

SIN10689P

Approval Date

January 20, 1999

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

May 30, 2025

ATC Business ID

XJ01CR02

Company Information

ManufacturerMedochemie Ltd – Factory B

Registrant

MEDOCHEMIE SINGAPORE PTE. LTD.

Licence Holder

MEDOCHEMIE SINGAPORE PTE. LTD.

Active Ingredients

CLAVULANATE POTASSIUM + MICROCRYSTALLINE CELLULOSE EQV TO CLAVULANIC ACID

Strength: 125 mg

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

Strength: 500 mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy